Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia

NCT05216614 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to obtain investigational product

Conditions

COVID-19
Olfactory Disorder
Parosmia

Interventions

DRUG: Fluvoxamine
DRUG: Placebo

Sponsor

Washington University School of Medicine